Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Blaming not only budget busting prices but also gargantuan portions on regular menus and other factors like shrinking ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Researchers couldn't be sure why the medicines, collectively known as GLP-1 agonists, may help in this way. But, experts ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

As well as shedding pounds and controlling diabetes, Ozempic and Wegovy can help you drink less, researchers suggest ...